Gilead Sciences (GILD) Announces Topline Selonsertib Phase 2 Data in NASH; Anti-Fibrotic Activity Noted
Go back to Gilead Sciences (GILD) Announces Topline Selonsertib Phase 2 Data in NASH; Anti-Fibrotic Activity NotedGilead Sciences (NASDAQ: GILD) | Delayed: 73.25 +0.24 (0.33%) | |||||
---|---|---|---|---|---|---|
Previous Close | $73.01 | 52 Week High | $108.63 | |||
Open | $73.25 | 52 Week Low | $71.39 | |||
Day High | $73.87 | P/E | 40.47 | |||
Day Low | $73.20 | EPS | $1.81 | |||
Volume | 8,369,725 |